• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX 0.41% $7.24

MAYNE PHARMA GROUP LIMITED - Corporate Spotlight

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company. The... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing generic pharmaceuticals. The Company operates through three segments: International, Branded Products Division (BPD) and Portfolio Products Division (PPD). Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. The BPD segment distributes medically differentiated specialty products in United States. The PPD segment distributes established products (branded and generic) in the United States on a portfolio basis. The Company's products include Doxycycline Capsules, Oxycodone IR Tablets, Erythromycin Capsules and others.More

No Corporate Spotlight currently available.

(20min delay)
Last
$7.24
Change
-0.030(0.41%)
Mkt cap ! $615.9M
Open High Low Value Volume
$7.27 $7.43 $7.23 $495.6K 67.67K

Buyers (Bids)

No. Vol. Price($)
11 588 $7.24
 

Sellers (Offers)

Price($) Vol. No.
$7.25 186 9
View Market Depth
Last trade - 14.16pm 07/05/2024 (20 minute delay) ?
Last
$7.26
  Change
-0.030 ( 0.14 %)
Open High Low Volume
$7.34 $7.43 $7.23 16274
Last updated 14.35pm 07/05/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.